In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Strongbridge Biopharma PLC

www.strongbridgebio.com

Latest From Strongbridge Biopharma PLC

More Positive Data For Recordati Cushing's Drug

With Isturisa, licensed last year from Novartis, it seems as though the Italian drugmaker has got hold of a therapy that could become lucrative, as well as highly effective for Cushing's disease.

Rare Diseases Clinical Trials

Recordati's Isturisa Approved For Cushing's In EU

Acquired from Novartis last year, Isturisa is forecast to have peak sales of over $100m. Now all eyes will be on a PDUFA date in March.

Approvals Rare Diseases

Deal Watch: Amgen Outsources Celiac Drug To Provention; Lilly, NextCure Will Co-Discover IO Drugs

Through its Provention collaboration, Amgen partnered with the team that worked on AMG 714 at Celimmune, which the big biotech bought in 2017. Lilly will partner with NextCure to use the latter's FIND-IO platform for immuno-oncology drug discovery.

Deals Business Strategies

Pipeline Watch: Phase III Progress With BL-8040, Recorlev And Estelle

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Metabolic Disorders
  • Musculoskeletal & Connective Tissue Disorders
  • Renal System
  • Alias(es)
  • Cortendo Invest AB
  • Cortendo AB
  • Cortendo PLC
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Strongbridge Biopharma PLC
  • Senior Management
  • A. Brian Davis, CFO
    Robert Lutz, CBO
    Fredric Cohen, MD, CMO
    Dave Bonnell, SVP, Sales & Mktg.
    Scott Wilhoit, Chief Commercial Officer
  • Contact Info
  • Strongbridge Biopharma PLC
    Phone: (46)(610) 254-9200
    900 Northbrook Dr., Ste. 200
    Trevose, PA 19053
    USA
UsernamePublicRestriction

Register